West Pharmaceutical Services (WST) stock price, revenue, and financials

West Pharmaceutical Services market cap is $8.8 b, and annual revenue was $1.51 b in FY 2016

$8.8 B

WST Mkt cap, 10-Jun-2019

West Pharmaceutical Services Income Statement

Annual

USDFY, 2013FY, 2014FY, 2016

Revenue

1.4b1.4b1.5b

Revenue growth, %

4%8%

R&D expense

36.8m

General and administrative expense

239.8m

Operating expense total

276.6m

EBIT

162.4m182.0m196.8m

EBIT margin, %

12%13%13%

Interest expense

17.0m16.5m8.1m

Interest income

1.9m3.5m1.1m

Pre tax profit

147.1m169.0m189.8m

Income tax expense

40.2m47.2m54.4m

Net Income

112.3m127.1m143.6m

Quarterly

USDQ3, 2013Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q2, 2016Q1, 2017Q3, 2017

Revenue

341.8m335.9m359.7m344.5m388.0m387.7m

R&D expense

9.6m7.5m8.1m8.5m10.3m

General and administrative expense

56.1m56.0m55.2m60.8m54.6m61.6m

Operating expense total

65.7m65.6m62.7m68.9m63.1m71.3m71.9m70.6m

EBIT

39.7m44.0m47.8m39.1m61.3m

EBIT margin, %

12%14%11%16%

Interest expense

4.4m4.1m3.4m3.7m2.0m2.1m

Interest income

400.0k400.0k400.0k500.0k300.0k

Pre tax profit

35.7m44.1m36.1m(6.7m)59.5m

Income tax expense

10.6m12.5m9.2m(6.6m)17.0m2.2m14.0m

Net Income

26.8m31.0m32.9m27.8m1.5m60.9m51.0m

West Pharmaceutical Services Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

230.0m255.3m203.0m

Accounts Receivable

179.0m200.5m

Inventories

181.5m199.3m

Current Assets

659.3m641.9m

PP&E

705.8m721.0m778.3m855.0m822.0m

Goodwill

108.6m103.0m

Total Assets

1.7b1.7b

Accounts Payable

108.0m103.1m122.0m

Short-term debt

Current Liabilities

252.5m241.0m

Long-term debt

309.5m226.2m197.0m196.0m

Total Debt

226.2m197.0m196.0m

Total Liabilities

599.2m

Additional Paid-in Capital

120.0m160.2m260.4m282.0m

Retained Earnings

805.0m902.2m1.1b

Total Equity

956.9m1.1b

Debt to Equity Ratio

0.2 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.7 x1.5 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q2, 2019

Cash

230.0m246.8m207.1m252.0m256.8m

Accounts Receivable

195.9m189.5m194.6m219.0m

Inventories

185.7m183.4m187.7m

Current Assets

679.5m625.1m680.9m

PP&E

682.0m712.0m694.8m675.8m689.5m822.0m

Goodwill

114.0m110.4m104.4m105.7m

Total Assets

1.7b1.6b1.7b1.8b

Accounts Payable

91.4m88.5m93.6m99.0m

Current Liabilities

242.5m296.6m299.9m289.0m300.0m

Long-term debt

315.5m231.9m231.5m198.0m196.0m

Total Debt

381.1m390.7m359.3m315.5m231.9m231.7m231.5m229.5m228.9m228.6m194.2m195.7m196.6m198.0m196.0m

Total Liabilities

703.2m654.9m671.2m593.0m

Additional Paid-in Capital

149.1m170.4m195.8m276.0m

Retained Earnings

825.0m878.7m927.2m947.0m939.9m978.0m1.1b1.3b

Total Equity

970.1m941.1m995.3m1.1b

Debt to Equity Ratio

0.2 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.7 x1.7 x1.7 x

West Pharmaceutical Services Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

127.1m95.6m143.6m

Depreciation and Amortization

81.0m84.8m86.1m88.1m

Accounts Receivable

(6.3m)(14.0m)(23.3m)

Inventories

(16.0m)(11.0m)(21.2m)(7.0m)

Accounts Payable

(3.5m)17.2m6.1m

Cash From Operating Activities

182.9m212.4m219.4m

Cash From Investing Activities

(104.0m)(129.5m)(175.8m)

Long-term Borrowings

(2.3m)(27.4m)(69.8m)

Dividends Paid

(29.1m)(32.4m)(35.8m)

Cash From Financing Activities

(30.8m)(41.5m)(113.9m)(109.0m)

Interest Paid

16.7m14.7m8.6m8.0m

Free Cash Flow

294.8m344.0m49.2m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

27.1m32.9m60.7m62.2m104.5m60.9m150.7m

Accounts Receivable

198.8m194.6m209.6m219.0m209.5m224.8m

Inventories

187.2m187.7m194.1m197.7m201.1m212.3m

Accounts Payable

91.4m93.6m97.5m107.3m99.0m106.1m

Cash From Operating Activities

73.0m3.0m106.0m45.0m127.0m

Cash From Investing Activities

(111.0m)(57.0m)

Long-term Borrowings

(68.0m)

Dividends Paid

(31.0m)

Cash From Financing Activities

(19.0m)(29.0m)

Free Cash Flow

(36.0m)39.0m17.0m

West Pharmaceutical Services Employee Rating

3.0200 votes
Culture & Values
3.0
Work/Life Balance
3.0
Senior Management
2.8
Salary & Benefits
3.3
Career Opportunities
3.1
Source